Lifespan

This study tests whether a low-barrier hepatitis C treatment program can help people in jail start and finish treatment more easily. Forty adults awaiting trial at the Rhode Island Department of Corrections will receive a 12-week course of the HCV medication Epclusa, and if relea…

This study tests two monthly buprenorphine shots (Sublocade and Brixadi) in 60 incarcerated adults with opioid use disorder who are about to be released from prison. The goal is to see which shot helps them stay in treatment longer after returning to the community, and whether le…